You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / WOCKHARDT

WOCKHARDT
Intrinsic Value | Fundamental Analysis

Returns | 1W : -5.7% , 1M : 8.9%,1Y : 52.1%
www.wockhardt.com
BOM : 532300     NSE : WOCKPHARMA    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Average [Stock is fairly valued]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : Average [>25% and <50%]
Oct 21,2021
Price(EOD): Rs. 462.05
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Affiliate Link.
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
WOCKHARDT -5.7% 8.9% 52.1%
SUN PHARMACEUTICAL INDUSTRIES -2.8% 7% 67.4%
DIVIS LABORATORIES -3.4% 0.2% 58.9%
DR REDDYS LABORATORIES -6.3% -4.3% -6.4%
CIPLA -0% -4.7% 15.7%
GLAND PHARMA -4.3% -6.3% NA
PIRAMAL ENTERPRISES -5.4% 2.7% 106.2%
CADILA HEALTHCARE -6.3% -7.3% 20.1%
TORRENT PHARMACEUTICALS -3.9% -1.2% 8.6%


FUNDAMENTAL ANALYSIS OF WOCKHARDT

 
Fundamentals Score
[ Q(TTM): Jun2021, Y: Mar2021
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]
Show Me the Stocks with Fundamentals better than WOCKHARDT Plus/Pro


VALUATION OF WOCKHARDT

 
Valuation Score
[As on : Oct 21,2021 ]

Ratio Consolidated
P/E
P/B
P/S
7.46
P/E Calculated based on EPS of 61.93
[ Mar2021 - Consolidated Results ]

1.53
P/B Calculated based on Book Value of 302.33
[ Mar2021 - Consolidated Results ]

1.72
P/S Calculated based on Revenues of 2969.58 Cr
[ TTM - Consolidated Results ]

Show Me the Stocks with Valuation better than WOCKHARDT Plus/Pro


FAIR VALUE OF WOCKHARDT

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
NA
-7%
-3%

SHARE PRICE MOMENTUM OF WOCKHARDT

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2021
2020
2019
Avg_3yrs
1.02
1.94
1.58
1.51
0.7
1.22
1.28
1.07
[Last Annual Data : Mar2021]

PLEDGED SHARES

Pledged Shares
41.99 %
As on : Sep2021

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
36.01%
233.99%
96.63%
93.84%
43.67%
249.26%
98.22%
97.08%
QtrlyTrend
8
Latest Qtr: Jun2021

WOCKHARDT related INDICES

BSE Indices1W1M1Y
S&P BSE 500 -1.8% 3.7% 63.3%
S&P BSE ALLCAP -1.9% 3.7% 64.4%
S&P BSE 400 MIDSMALLCAP -3.6% 5% 88.2%
S&P BSE HEALTHCARE -3.7% -3.1% 29.7%
S&P BSE MIDSMALLCAP -3.7% 4.2% 88.4%
S&P BSE 250 SMALLCAP -3.7% 5.1% 94.4%
S&P BSE SMALL CAP -4.1% 4.2% 97.2%
NSE Indices1W1M1Y
NIFTY500 MULTICAP 50:25:25 -1.2% 5.4% NA
NIFTY 500 -1.8% 3.6% 63%
NIFTY MID SMALL400 -3.6% 5.3% 88.4%
NIFTY SMALLCAP250 -3.7% 4.9% 95.6%
NIFTY SMALLCAP 50 -4% 4.3% 91.7%
NIFTY FREE SMALL 100 -4.2% 5% 94.5%

You may also like the below Video Courses


FAQ [Frequently Asked Questions]


Is WOCKHARDT good for long term investment?

As on 21-Oct-2021, the Fundamentals of WOCKHARDT look Poor and hence it may not be good for long term investment ! See Financial Performance of WOCKHARDT . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is WOCKHARDT UnderValued or OverValued?

As on 21-Oct-2021, WOCKHARDT is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!

What is the Intrinsic Value of WOCKHARDT ?

As on 21-Oct-2021, the Intrinsic Value of WOCKHARDT is Rs. 488.58 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. -252.22
Fair Value [Median EV / Sales Model] : Rs. 498.60
Fair Value [Median Price / Sales Model] : Rs. 478.57
Median Fair Value of WOCKHARDT : Rs. 488.58

Is WOCKHARDT trading at a Premium or Discount?

As on 21-Oct-2021, WOCKHARDT is trading at a Discount of -5% based on the estimates of Median Intrinsic Value!

What is the Financial Performance of Industry Peers of WOCKHARDT ?

Check out Annual Financials of Industry Peers
Share Price & Financials of SUN PHARMACEUTICAL INDUSTRIES LTD | BOM: 524715 | NSE: SUNPHARMA
Share Price & Financials of DIVIS LABORATORIES LTD | BOM: 532488 | NSE: DIVISLAB
Share Price & Financials of DR REDDYS LABORATORIES LTD | BOM: 500124 | NSE: DRREDDY
Share Price & Financials of CIPLA LTD | BOM: 500087 | NSE: CIPLA
Share Price & Financials of GLAND PHARMA LTD | BOM: 543245 | NSE: GLAND
Check out Quarterly Results of Industry Peers
Quarterly Results of SUN PHARMACEUTICAL INDUSTRIES LTD
Quarterly Results of DIVIS LABORATORIES LTD
Quarterly Results of DR REDDYS LABORATORIES LTD
Quarterly Results of CIPLA LTD
Quarterly Results of GLAND PHARMA LTD

What are the Frequent Comparisons in this Industry?

Compare Analytics
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of GLAND PHARMA LTD

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z